Bococizumab (Anti-PCSK9)

Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.

• Supplier: Selleck Chemicals
• Product #: A2788
• Sku #: A2788-1mg*25